Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy

Oncoimmunology

Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, …, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger

• DOI: 10.1080/2162402x.2022.2152998
• PMID: 36531688
• PMCID: PMC9757483